Mr. Edwards, a veteran of the global pharmaceuticals industry, spent 21 years at
"Jeff is a proven financial executive with extensive commercial, corporate development and public company management experience, and I would like to welcome him on behalf of everyone at Clearside,” said
Mr. Edwards succeeds
“On behalf of everyone at Clearside, I would like to thank Evgeny for his many contributions to the company, both before and after it went public,” said Mr. Humphries. “Evgeny championed an anchor investment in the company’s Series B financing by
About Clearside
Cautionary Note Regarding Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “believe”, “expect”, “may”, “plan”, “potential”, “will”, and similar expressions, and are based on Clearside’s current beliefs and expectations. These forward-looking statements include expectations regarding the clinical development of Clearside’s product candidates, and the timing of a potential submission of an NDA with the